The latest medical news on Clinical Pharmacology

The research magnet gathers the latest research from around the web, based on your specialty area. Below you will find a sample of some of the most recent articles from reputable medical journals about clinical pharmacology gathered by our medical AI research bot.

The selection below is filtered by medical specialty. Registered users get access to the Plexa Intelligent Filtering System that personalises your dashboard to display only content that is relevant to you.

Want more personalised results?

Request Access
New Drug Approvals

DUBLIN, Nov. 20, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the U.S. Food and Drug Administration (FDA) accelerat...

Clinical Trial Results

19 November 2024 -- GSK plc (LSE/NYSE: GSK) today announced positive headline results of GLISTEN, the ongoing global phase III clinical trial evalu...

Drugs FDA Alerts

Audience: Healthcare Provider, Pharmacy, Consumer November 20, 2024 -- MXBBB is voluntarily recalling 1 lot of UMARY ACID HYALURONIC, 30 CAPLETS 85...

New Drug Approvals

Brussels (Belgium), November 20, 2024 – 07:00 (CET) – UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Adminis...

Clinical Trial Results

PRINCETON, N.J., Nov. 14, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company fo...

Clinical Trial Results

RAHWAY, N.J.--(BUSINESS WIRE) November 19, 2024 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positi...

Clinical Trial Results

PASADENA, Calif., Nov. 19, 2024. Huntington Medical Research Institutes (HMRI), a pioneer in scientific research with a track record of groundbreak...

Drugs FDA Alerts

Audience: Healthcare Provider, Pharmacy, Consumer November 19, 2024 -- Endo, Inc. (OTCQX: NDOI) (“Endo”) announced today that one of its operating ...

Clinical Trial Results

SPRING HOUSE, Pa. (November 18, 2024) – Johnson & Johnson (NYSE: JNJ) today announced positive topline results from ICONIC-LEADa, a pivotal Phase 3...

Clinical Trial Results

INDIANAPOLIS, Nov. 18, 2024. Eli Lilly and Company today announced positive Phase 2 results for muvalaplin, an investigational once-daily, orally a...

Clinical Trial Results

PALO ALTO, Calif., Nov. 18, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmace...

New Drug Applications

NEW YORK, Sept. 18, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pi...